Nuveen Asset Management, LLC C4 Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 192,424 shares of CCCC stock, worth $575,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,424

Previous 180,853 6.4%

Holding current value

$575,347

Previous $1.03 Million 32.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.6 - $7.0 $41,655 - $80,997	11,571 Added 6.4%	192,424 $692,000
Q3 2024 Nov 14, 2024	SELL	$4.43 - $7.38 $1.11 Million - $1.85 Million	-250,160 Reduced 58.04%	180,853 $1.03 Million
Q2 2024 Aug 09, 2024	BUY	$4.05 - $8.1 $1.75 Million - $3.49 Million	431,013 New	431,013 $1.99 Million
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $64,836 - $188,653	-20,915 Reduced 5.54%	356,609 $1.12 Million
Q4 2022 Feb 14, 2023	SELL	$5.42 - $10.24 $132,031 - $249,446	-24,360 Reduced 6.06%	377,524 $2.23 Million
Q3 2022 Nov 14, 2022	SELL	$8.03 - $12.77 $49,585 - $78,854	-6,175 Reduced 1.51%	401,884 $3.52 Million
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $62,718 - $327,971	-12,395 Reduced 2.95%	408,059 $3.08 Million
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $3.14 Million - $5.22 Million	157,052 Added 59.62%	420,454 $9.77 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $1.29 Million - $2.06 Million	-43,934 Reduced 14.3%	263,402 $7.47 Million
Q3 2021 Nov 12, 2021	BUY	$35.91 - $50.5 $3.84 Million - $5.4 Million	106,944 Added 53.37%	307,336 $15.4 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $2.95 Million - $4.09 Million	97,078 Added 93.96%	200,392 $7.58 Million
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $2.51 Million - $3.66 Million	78,690 Added 319.57%	103,314 $3.82 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $561,427 - $912,319	24,624 New	24,624 $816,000

Others Institutions Holding CCCC

# of Institutions

126

Shares Held

63M

Call Options Held

651K

Put Options Held

115K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $146M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC C4 Therapeutics, Inc. Transaction History